For the Inventor, By the Inventor

Enter assignee name

New Haven, CT, United States of America

Molecular Staging Inc.

USPTO Granted Patents = 17

% Expired Patents = 17.6

Trademarks = 2

Forward Citations = 1,507

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Roger S Lasken (6 out of 12 patents)

Sherman M Weissman (4 out of 29 patents)

Stephen F Kingsmore (3 out of 5 patents)

4. Gyanendra Kumar (3 out of 6 patents)

5. Xinghua Pan (2 out of 8 patents)

6. Frank B Dean (2 out of 6 patents)

7. Rajanikanth Bandaru (2 out of 2 patents)

8. Patricio Abarzúa (2 out of 2 patents)

9. Jeremy P Lambert (2 out of 2 patents)

10. R Steven Wiltshire (2 out of 2 patents)

11. Patricia Bray-Ward (1 out of 6 patents)

12. Patricio Abarzúa (1 out of 6 patents)

13. Gregory John Hafner (1 out of 6 patents)

14. Michael J Lane (1 out of 11 patents)

15. James Langham Dale (1 out of 11 patents)

17 patents: Sort by Forward Citations

1. 6830884 - Method of amplification (2004-12-14),

2. 6811986 - 5′-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms (2004-11-02),

3. 6777183 - Process for allele discrimination utilizing primer extension (2004-08-17),

4. 6686157 - Signal amplification with lollipop probes (2004-02-03),

5. 6670126 - Poly-primed amplification of nucleic acid sequences (2003-12-30),

6. 6635425 - 5′-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms (2003-10-21),

7. 6617137 - Method of amplifying whole genomes without subjecting the genome to denaturing conditions (2003-09-09),

8. 6573051 - Open circle probes with intramolecular stem structures (2003-06-03),

9. 6531283 - Protein expression profiling (2003-03-11),

10. 6498023 - Generation of single-strand circular DNA from linear self-annealing segments (2002-12-24),

11. 6372434 - Methods for reducing the complexity of DNA sequences (2002-04-16),

12. 6368801 - Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase (2002-04-09),

13. 6323009 - Multiply-primed amplification of nucleic acid sequences (2001-11-27),

14. 6291187 - Poly-primed amplification of nucleic acid sequences (2001-09-18),

15. 6287825 - Methods for reducing the complexity of DNA sequences (2001-09-11),

Company Overview

Molecular Staging Inc., based in New Haven, CT, specializes in advanced molecular diagnostics and genomic technologies. The company focuses on developing innovative solutions for cancer detection and personalized medicine, leveraging cutting-edge research in molecular biology and bioinformatics. By integrating sophisticated analytical techniques, Molecular Staging aims to enhance the accuracy of disease diagnosis and treatment strategies, contributing to the evolving landscape of precision healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

17 Patents

#14 in New Haven, CT

#444 in Connecticut

#18,881 in US

#35,887 in the World

New Haven, CT, United States of America

Molecular Staging Inc.

Forward Citations = 1,507

26 inventors:

Roger S Lasken (6 out of 12 patents)

Sherman M Weissman (4 out of 29 patents)

Stephen F Kingsmore (3 out of 5 patents)

4. Gyanendra Kumar (3 out of 6 patents)

5. Xinghua Pan (2 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Molecular Staging Inc.. Retrieved from https://idiyas.com/company/molecular-staging

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…